Resmed (RMD) Restructuring Costs (2015 - 2025)

Resmed's (RMD) quarterly Restructuring Costs came in at $5.9 million in Q4 2025, down 62.44% on a QoQ basis from $15.8 million in Q3 2025.

Resmed (RMD) Restructuring Costs (2015 - 2025) Analysis & Trends

Resmed (RMD) has 10 years of Restructuring Costs data on file, last reported at $5.9 million in Q4 2025.

Quarterly Restructuring Costs changed N/A year-over-year to $5.9 million in Q4 2025, while the trailing twelve-month figure through Mar 2026 was $21.7 million (changed N/A YoY) and the FY2024 annual result came in at $64.2 million, up 598.13% from the prior year.
Restructuring Costs eased to $5.9 million in Q4 2025, from $15.8 million in the prior quarter.
In the past five years, Restructuring Costs ranged from a high of $15.8 million in Q3 2025 to a low of -$8.7 million in Q2 2021.
A 4-year average of $4.3 million and a median of $5.9 million in 2025 frame the typical range for Restructuring Costs.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Intuitive Surgical	132.71 Bn	127.50 Bn	1.96 Bn
2	Becton Dickinson	51.57 Bn	50.71 Bn	2.32 Bn
3	Alcon	35.52 Bn	34.17 Bn	1.68 Bn
4	Resmed	33.28 Bn	31.81 Bn	861.22 Mn
5	Medline	27.86 Bn	25.18 Bn	2.22 Bn
6	West Pharmaceutical Services	25.15 Bn	24.71 Bn	329.20 Mn
7	Solventum	15.31 Bn	14.91 Bn	1.29 Bn
8	Cooper Companies	14.86 Bn	14.72 Bn	735.40 Mn
9	Baxter International	13.63 Bn	11.48 Bn	1.03 Bn
10	Align Technology	11.37 Bn	10.27 Bn	757.43 Mn

Download Data